R
Ribonova
0 followers
RiboNova is a privately-held biopharmaceutical company based in the Lankenau Institute for Medical Research near Philadelphia, Pennsylvania. Their product pipeline includes a Phase-2 ready small molecule drug for the treatment of all forms of genetically-confirmed mitochondrial disease.
Org chart
Nigel L. Webb
President, CEO & Board Member
Nigel L. Webb
Collapse
Yucynthia A. Jean-Louis
Chief Business Officer
Anthony W. Ford-Hutchinson
Chief Scientific Officer & Board Member
Board & advisors
Theodore J. Torphy
Chairman
Jane H. Hollingsworth
Board Member
Robert T. Sarisky
Board Member
Marni J. Falk
Scientific Advisor
George C. Prendergast
Scientific Advisor
Eric Yuen
Scientific Advisor